Ed D. Schuuring - Publications

Corrigendum to "Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands" [Eur J Cancer 205 (2024)114125].

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 25, 2026

Radiotherapy Response Prediction in Myxofibrosarcomas and Undifferentiated Soft Tissue Sarcomas Using DNA Methylation and Copy Number Profiling.

Journal: International journal of surgical pathology

Published: January 29, 2026

Young women with (pre)malignant cervical disease in northern Netherlands: what characterises them - A population-based cohort study.

Journal: BMC women's health

Published: January 26, 2026

PAX1 and ZNF582 Methylation as a Triage Strategy in Cytologic and hrHPV+ Scrapings in Both Chinese and Dutch Cohorts.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: January 04, 2026

Large language model-based approach for low-cost, rapid and accurate automated extraction of predictive biomarker testing results from Dutch pathology reports.

Journal: Virchows Archiv : an international journal of pathology

Published: August 21, 2025

Real-world evidence of RET fusion prevalence and testing in patients with metastatic non-small cell lung cancer.

Journal: Translational oncology

Published: August 15, 2025

Reference materials and external quality assessment for liquid biopsy assays: Expert opinions from the European Liquid Biopsy Society ctDNA workshop.

Journal: Cancer treatment and research communications

Published: July 14, 2025

Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors-An Explorative Study.

Journal: International journal of molecular sciences

Published: July 01, 2025

Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose Osimertinib.

Journal: Targeted oncology

Published: May 07, 2025

Clinical validation of a three-marker methylation panel to detect CIN3+ in vaginal self-samples in the Dutch population-based screening programme.

Journal: Clinical epigenetics

Published: April 13, 2025

The Association Between Clinical Outcome and Expression of DNMT1, 3A, and 3B in Locally Advanced Laryngeal Carcinomas Treated by Definitive Radiotherapy.

Journal: Cancers

Published: March 23, 2025

Authors' Reply "Non-Smoking and Non-Drinking Oral Cancer Patients Are at Higher Risk of Second Primary Tumours".

Journal: Oral diseases

Published: March 06, 2025